IFN-γ suppresses melanoma tumor growth [12, 13] by inducing ubiquitin-specific peptidase 18 (USP18) and sensitizing tumor cells to immunosurveillance [12], which may be limited by tumor-associated macrophages (TAMs) [14]. The gene discussed is IFNG; the disease is neoplasm.